Overview

A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This I/II study will evaluate to see how safe and useful irreversible electroporation (also called NanoKnife) is in patients with locally advanced pancreatic cancer.
Phase:
N/A
Details
Lead Sponsor:
University Health Network, Toronto